Adriamycin treatment of advanced vulvar carcinoma

Deppe, G.; Bruckner, H.W.; Cohen, C.J.

Obstetrics and Gynecology 50(1 Suppl): 13s-14s

1977


ISSN/ISBN: 0029-7844
PMID: 876532
Document Number: 122007
Four consecutive patients with measurable recurrent squamous cell carcinoma of the vulva were treated with Adriamycin, in small doses approximately 45 mg/square meter of body surface area every 3 weeks. Three patients achieved objective regression of nodal metastases and residual tumor with clinical subjective benefit. Tumor control was maintained for 32, 31+, and 28+ weeks.

Document emailed within 1 workday
Secure & encrypted payments